Is JNCE a buy or a sell?
The Discounted Cash Flow (DCF) valuation of Jounce Therapeutics Inc (JNCE) is (19.02) USD. With the latest stock price at 1.88 USD, the upside of Jounce Therapeutics Inc based on DCF is -1111.7%. This means that JNCE is a sell according to the DCF valuation model.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.6% - 7.8% | 7.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (39.65) - (12.27) | (19.02) |
| Upside | -2209.0% - -752.6% | -1111.7% |